Industry News
RevBio Awarded a $2 Million Follow-On NIH Grant to Reduce Opioid Use and Addiction with TETRANITE
RevBio announced that it has received a grant from the National Institutes of Health...
Industry News
RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization
RevBio announced that it has received approval from the U.S. Food and Drug Administration...
Industry News
RevBio is Awarded a $2 Million Grant
RevBio, Inc., announced that it has been awarded a $2 million Phase II Small...
Industry News
RevBio Receives a Strategic Investment from Pacific Dental Services to Support Ongoing Clinical Trials in Implant Dentistry
RevBio announced that it has received a strategic investment from Pacific Dental Services (PDS)...